Enfusion Inc’s recent filing unveils that its General Counsel Campobasso Matthew unloaded Company’s shares for reported $6032.0 on Oct 22 ’24. In the deal valued at $8.95 per share,674 shares were sold. As a result of this transaction, Campobasso Matthew now holds 53,627 shares worth roughly $0.48 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Campobasso Matthew bought 674 shares, generating $6,031 in total proceeds.
Before that, Bastone Bronwen sold 3,219 shares. Enfusion Inc shares valued at $26,138 were divested by the Chief People Officer at a price of $8.12 per share. As a result of the transaction, Bastone Bronwen now holds 195,694 shares, worth roughly $1.75 million.
A number of analysts have revised their coverage, including Goldman’s analysts, who decreased its forecast for the stock in late February from “a Neutral” to “a Sell”. JP Morgan also remained covering ENFN and has decreased its forecast on January 30, 2024 with a “an Underweight” recommendation from previously “Neutral” rating. UBS started covering the stock on November 07, 2023. It rated ENFN as “a Neutral”.
Price Performance Review of ENFN
On Tuesday, Enfusion Inc [NYSE:ENFN] saw its stock jump 2.64% to $8.95. Over the last five days, the stock has lost -3.24%. Enfusion Inc shares have fallen nearly -7.73% since the year began. Nevertheless, the stocks have risen 4.07% over the past one year. While a 52-week high of $10.45 was reached on 09/20/24, a 52-week low of $7.52 was recorded on 01/30/24. SMA at 50 days reached $8.77, while 200 days put it at $8.86.
Levels Of Support And Resistance For ENFN Stock
The 24-hour chart illustrates a support level at 8.79, which if violated will result in even more drops to 8.63. On the upside, there is a resistance level at 9.06. A further resistance level may holdings at 9.17. The Relative Strength Index (RSI) on the 14-day chart is 50.53, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.05, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 59.44%. Stochastics %K at 34.06% indicates the stock is a holding.
How much short interest is there in Enfusion Inc?
A steep rise in short interest was recorded in Enfusion Inc stocks on 2024-10-15, dropping by -0.34 million shares to a total of 1.52 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-13 was 1.86 million shares. There was a decline of -22.47%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on April 03, 2023 when Piper Sandler began covering the stock and recommended ‘”a Neutral”‘ rating along with a $11 price target.
